Preview Mode Links will not work in preview mode
Advertisement

Apr 30, 2021

In part 2 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about funding for medical research in the U.S.


Apr 29, 2021

In part 1 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about the Veterans Affairs Centers of Excellence.


Apr 28, 2021

Dr. Peter Marks discusses the Johnson & Johnson COVID-19 vaccine.


Apr 27, 2021

Professor Maria Eriksdotter discusses whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk.


Apr 26, 2021

Dr. Martijn Wijburg discusses pharmacovigilance of patients treated with disease-modifying therapies for MS.

Show references:

https://pubmed.ncbi.nlm.nih.gov/33229453/